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Abstract
Background: Skeletal muscle tissue has an enormous regenerative capacity that is instrumental for a successful
defense against muscle injury and wasting. The peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α)
exerts therapeutic effects in several muscle pathologies, but its role in damage-induced muscle regeneration is
unclear.
Methods: Using muscle-specific gain- and loss-of-function models for PGC-1α in combination with the myotoxic
agent cardiotoxin (CTX), we explored the role of this transcriptional coactivator in muscle damage and
inflammation.
Results: Interestingly, we observed PGC-1α-dependent effects at the early stages of regeneration, in particular
regarding macrophage accumulation and polarization from the pro-inflammatory M1 to the anti-inflammatory M2
type, a faster resolution of necrosis and protection against the development of fibrosis after multiple CTX-induced
injuries.
Conclusions: PGC-1α exerts beneficial effects on muscle inflammation that might contribute to the therapeutic
effects of elevated muscle PGC-1α in different models of muscle wasting.
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Background
Despite being a mostly postmitotic tissue with very high
cellular plasticity, skeletal muscle has a tremendous
capacity for regeneration upon injury. The regenerative
process in skeletal muscle is highly organized and
complex, requiring the coordinated activation of multiple
cells types and factors [1]. Heavily damaged muscle fibers
undergo necrosis, and as a consequence, muscle-resident
mast cells and macrophages are first activated to eradicate
cell debris and ultimately make room for newly formed
muscle fibers [2]. By secreting cytokines such as tumor
necrosis factor α (TNFα) and interleukin 6 (IL-6), these
cells subsequently attract neutrophils, which invade the
damaged area within hours [2]. Neutrophils in turn
contribute to the secretion of a myriad of chemokines
including monocyte chemoattractant protein 1 (MCP-1)
and macrophage inflammatory proteins (MIP-1α, MIP-1β),
which promote the invasion of monocytes from the blood
stream.
Resident tissue macrophages and invading monocytes
are polarized into the pro-inflammatory M1-type to
phagocyte necrotic tissue and promote an environment
that favors satellite cell activation and proliferation. Over
a period of several days, M1 macrophages are replaced
by M2 macrophages, whose role is to suppress the
process of inflammation and produce extracellular
matrix components that serve as scaffold for the forma-
tion of new muscle tissue. The M2 macrophages are
thus essential for the switch from the proliferative to the
differentiation stage of regeneration. Importantly, timely
attraction of macrophages, the switch between subclasses,
and the precise termination of the activity of these cells at
the end of the regenerative process are prerequisites for
the successful activation, proliferation, and differentiation
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of muscle progenitor cells. For example, despite their
anti-inflammatory and pro-regenerative properties, pro-
longed presence of M2 macrophages leads to uncontrolled
activation and proliferation of fibroblasts and overproduc-
tion of extracellular components resulting in fibrosis [3].
This excessive formation of fibrous tissue prevents the
full functional recovery of muscle tissue.
Exercise training not only boosts the resistance of
muscle against damage but might also enhance muscle
fiber regeneration by expanding the satellite cell pool
amongst other adaptions [4]. In addition, the transition
from myoblast proliferation to myofiber differentiation is
marked by a prominent switch from glycolysis to oxida-
tive metabolism of glucose and lipids [5]. Intriguingly,
the peroxisome proliferator-activated receptor γ coacti-
vator 1α (PGC-1α) is a key regulator of endurance exer-
cise adaptation in skeletal muscle and promotes oxidative
metabolism in muscle and other organs [6]. Accordingly,
transgenic overexpression of PGC-1α in muscle is suffi-
cient to trigger a shift from glycolytic to oxidative muscle
fibers [7] and a high endurance phenotype [8]. Muscle-
specific PGC-1α knockout mice inversely exhibit reduced
endurance, dysregulation of glucose homeostasis, fiber
damage, and systemic inflammation [9]. Due to its potent
effect on muscle plasticity, PGC-1α overexpression
protects muscles against denervation- and hind limb
unloading-induced fiber atrophy [10, 11], sarcopenia [12],
Duchenne muscular dystrophy in mdx and dystrophin/
utrophin double-knockout mice [13–15], a mitochondrial
myopathy [16], or muscle wasting promoted by statin
drugs [17]. While several candidate mechanisms for this
broad therapeutic effect of PGC-1α have been proposed
[18], it is still unclear how PGC-1α reduces muscle
damage and wasting in these highly divergent disease
contexts. Intriguingly, in all of these studies, PGC-1α
improved not only muscle function but also muscle cell
morphology and integrity, implying a potential role for
PGC-1α in fiber repair and regeneration.
Thus, to study the involvement of PGC-1α in muscle
damage and inflammation, we assessed the consequence
of specific gain- and loss-of-function of muscle PGC-1α
in mice treated with the myotoxic agent cardiotoxin
(CTX). PGC-1α-dependent differences in macrophage
accumulation, initiation of polarization, and removal
of necrotic tissue in earlier stages, as well as fibrosis in
later stages of regeneration, were noticeable in these
models. Nevertheless, late-stage functional recovery was
unaffected, even in mice with an ablation of muscle
PGC-1α.
Methods
Animals
PGC-1α transgenic mice (mTG) express PGC-1α under
the control of muscle creatine kinase (MCK) promoter
and have been previously described [7]. A muscle-specific
PGC-1α knockout model (mKO) was generated by cross-
ing a PGC-1αflox/flox line [19] with a Myf5-cre line (The
Jackson Laboratory, stock number 007845). The genotype
of the mice was determined by PCR from toe biopsies
using specific primers (Additional file 1). Since the Myf5-
cre line used to generate the mKO mice is in a mixed
strain background in contrast to the clean C57BL/6 J
background of the mTG animals [7], we used separate
littermate controls for each genotype (referred to as wild
type, WT). In this study, male 8–12-week-old mice were
used unless stated otherwise. All experimental procedures
performed on the mice were approved by the Cantonal
and institutional authorities.
Endurance capacity
Endurance capacity was determined by using a closed
treadmill (Columbus Instruments) with a 5° incline.
Mice were acclimatized for 2 days. The endurance tests
started at 8 m/min for 3 min, with increasing the speed
by 2 m/min every 3 min until exhaustion. Data were col-
lected before and during the running protocol and used
for calculating maximal oxygen consumption (VO2max)
and respiratory exchange ratio (RER) based on indirect
calorimetry.
Cardiotoxin injury
In anesthetized mice (O2/sevoflurane, 3 % sevoflurane)
kept on a warm plate, the lower limbs were shaved and
cleaned using 70 % ethanol. Thirty microliters of control
vehicle (phosphate buffered saline (PBS)) or 30 μl (3 μg)
of CTX (C9759, Sigma) was injected in the belly of
the tibialis anterior (TA) muscle using insulin syringes
(U-100, 300 μl, 29 G × 1/2 in.). Mice were sacrificed
at various time points after the injury and TA muscles
collected, transversally cut into two pieces, and frozen for
histology or RNA isolation. In the repeated injury model,
CTX was intramuscularly injected three times with a
3-week interval between injections. Three weeks after
the last injection, the mice were sacrificed and TAs
collected.
Histology
Half of a TA muscle was placed in OCT (Tissue-Tek,
Sakura) in plastic molds and frozen in isopentane pre-
cooled in liquid nitrogen. Eight-μm-thick sections were
cut with a cryostat (Leica CM1950) and stored at −20 °C.
Hematoxylin and eosin (Sigma MHS32, HT110232) stain-
ing (H&E), nicotinamide adenine dinucleotide (NADH)
staining, and Masson’s trichrome (Sigma HT15, HT1079,
HT10132) staining were performed on dried sections fixed
with paraformaldehyde (PFA) according to the manufac-
turer’s instructions and mounted with Eukitt mounting
medium (O. Kindler). For NADH staining, sections were
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incubated with NADH (Sigma, N-8129) and nitroblue
(Sigma, N-5514) for 30 min at 37 °C and then mounted.
Immunostainings were performed on dried fixed sections,
blocked with 3 % bovine serum albumin (BSA) in PBS,
followed by primary antibody incubation (laminin ab11575
Abcam, DAPI 62248 Thermo Scientific, CD68 MCA19
57GA Serotec). After washing with PBS, sections were
incubated with secondary antibodies (donkey-anti-rabbit
IgG Alexa647 A31573 Life Techologies, goat-anti-rat IgG
Alexa488 A11006 Invitrogen) then washed with PBS and
mounted with Vectashield (H-1000 Vector).
Hydroxyproline measurement
After multiple CTX injections, TA muscles were collected
and processed for sprectrophotometric measurement
of hydroxyproline content as an estimate of amount of
fibrotic tissue. Briefly, whole muscles were homogenized,
heated in 37 % HCl, and then incubated with chloramine
T and Ehrlich’s reagent before measuring absorbance at
560 nm. Measurements were normalized using a standard
curve.
Macrophage isolation and FACS
To isolate macrophages after CTX injections, TA muscles
were minced and digested in 2 mg/ml collagenase A solu-
tion (Roche Diagnostics), after which liberated cells where
filtered and macrophages recovered through density gradi-
ent separation in 30 % Percoll solution. For fluorescence-
activated cell sorting (FACS), cells were blocked with
Fc-receptor blocker (Innovex Biosciences Cat# NB309-5S)
and then stained with antibodies against F4/80, CD80 and
CD163 (mouse anti-F4/80 APC conjugated: BioLegend
Cat#123116, mouse anti-CD80 Pacific-Blue conjugated:
BioLegend Cat#104724, rabbit anti-CD163/M130 poly-
clonal antibody AlexaFluor488 conjugated: Bioss (Lucerna
Chem) Cat#bs-2527R-A488). For each sample, 50,000
events were collected and gated for total macrophages
(F4/80+), M1 (F4/80+CD80+CD163−) and M2 (F4/80
+CD80-CD163+) subpopulations. The data were analyzed
using FlowJo v10. To isolate macrophages from uninjured
muscles, TA, gastrocnemius, and quadriceps muscles
of adult mice at the age of 20–26 weeks were pooled
to obtain enough cells. The procedure was similar as
described above, using collagenase B solution (Roche
Diagnostics) to digest the muscles. Cell viability was
verified by Propidium Iodide (BioLegend Cat#421301).
Image acquisition and quantification
Images of immunostained muscle sections were acquired
with a Zeiss LSM700 microscope using the Zen 2010
software and a 25x objective with 0.5 zoom. H&E,
NADH, and Masson’s trichrome staining images were
captured using an Olympus IX81 with a 4x objective.
The entire area of the muscle sections was acquired and
quantification was performed on the complete area using
the ImageJ software. Intensity of NADH staining, area of
macrophage staining (CD68+ area), and necrotic area were
measured using the same software. Necrotic tissue assess-
ment was based on the morphology and coloration of the
fibers in H&E sections (swollen pink fibers as necrotic vs.
small purple fibers as regenerating) as well as with the
help of the CD68+ cells indicating the actively regene-
rating area. Fiji together with the Weka plugin was applied
for measuring fibrosis. The obtained probability images
were subsequently used for assessing fibrotic area using
the same threshold for all the samples within one experi-
ment. Quantification was performed in a blinded manner.
RNA extraction and relative qPCR
Total RNA was extracted from half of a TA muscle
using TRI Reagent (Sigma) and lysing matrix tubes
(MP Biomedicals) according to the manufacturer’s
instructions. After measuring RNA concentration on a
Nanodrop 1000 (Thermo Scientific), 1 μg was treated with
DNase I (Invitrogen) and used for cDNA synthesis by the
reverse transcriptase Superscript II (Invitrogen). Relative
messenger RNA (mRNA) levels were measured by quan-
titative PCR (qPCR) on a StepOne machine with SYBR
green-based detection and normalized to TATA binding
protein (TBP) expression using the ΔΔCt method. A list
of primers is provided in Additional file 1.
Muscle contractility measurements in situ
TA muscle regeneration was evaluated by measuring in
situ isometric muscle contraction in response to nerve
stimulation as previously described [20]. Briefly, mice were
anesthetized using a pentobarbital solution (ip, 60 mg/kg),
and supplemental doses were given as required to main-
tain deep anesthesia during the experiments. Each hind
paw was fixed with clamps to a platform, and the knees
were immobilized using stainless steel pins. The distal
tendons of the muscles were attached to an isometric
transducer (Harvard Bioscience) using a silk ligature. The
sciatic nerves were proximally crushed and distally stimu-
lated with a bipolar silver electrode using supramaximal
square wave pulses of 0.1 ms duration. All data provided
by the isometric transducer were recorded and analyzed
using the PowerLab software (4SP, AD Instruments).
Isometric measurements were made at an initial length L0
(the length at which maximal tension was obtained during
the tetanus). Responses to tetanic stimulation (pulse
frequency from 6.25, 12.5, 25, 50, 100, and 143 Hz)
were successively recorded and maximal tetanic force
(P0) was determined. Muscle mass was measured to
calculate specific force (P0 [g]/weight [g]). Finally, fatigue
resistance was assessed with one continuous contraction
(50 Hz for 45 s), measuring the time to reach 50 % of the
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initial force. After contractile measurements, the mice
were sacrificed with an overdose of anesthetic solution.
Statistical analysis
All data are presented as individual values or average ±
SEM. CTX-injured muscle gene expression values were
normalized to the PBS values of WT animals unless
stated otherwise. Statistical analysis was performed using
Student’s t test for comparison of two groups, and p ≤
0.05 was considered significant.
Results
Macrophage polarization shift in mTGs
Activation of macrophages and the subsequent shift
from the M1- to the M2-type are physiological processes
which unfold during regeneration and are associated
with the progression from myoblast proliferation towards
their fusion [3]. In order to assess the baseline condition
regarding abundance of pan- as well as polarized M1 and
M2 macrophages, we performed FACS analysis of muscles
of untreated mice. In this context, mTG mice have ap-
proximately 25 % more F4/80+ macrophages compared to
WT animals (Fig. 1a). Although there is a significant
difference between WT and mTGs regarding the propor-
tion of F4/80+CD80+CD163- M1 macrophages, this diffe-
rence is very small (1.3 % in WT vs 0.2 % in mTG) and
the amount of M1 macrophages seems neglectable in
healthy muscles. In contrast, a large proportion of the
tissue resident macrophages are polarized towards an M2
phenotype (~40 % in WT and ~60 % in mTG). The higher
proportion of polarized M2 macrophages in mTG animals
suggests that the muscles of these animals might be
preconditioned for faster repair and regeneration. This
preconditioning is also partly supported by qPCR data
showing higher expression levels of TGFβ and a substan-
tial reduction of IL-12 expression in basal, non-injured
state (Fig. 1c). To investigate whether the preconditioning
of these mice also alter the regeneration kinetics, CTX
was injected into the TA muscles and abundance of
pan-macrophages (F4/80+) as well as the relative numbers
of M1 (F4/80+CD80+CD163-) and M2 (F4/80+CD80-
CD163+) macrophages were measured by FACS. At 1 and
3 days post-injection, a remarkable infiltration of
macrophages was observed (Fig. 1b) with no differ-
ence between WT and mTG animals. One day after
the injection, the proportion of M1 macrophages was
~75 % whereas the amount of M2 macrophages was
very low in both genotypes. In mTG animals, the
proportion of M1 macrophages dropped to 66 % at
day 3 and was approximately 10 % lower compared
to WT animals.
One of the main roles of M1 macrophages is the
removal of necrotic debris, which could be impaired in
the mTG mice due to the faster decrease in the proportion
of M1 macrophages. We therefore performed H&E
stainings in order to assess the overall morphology of
the muscle tissue 4 days after CTX, combined with
immunohistochemical stainings for CD68+ macrophage-
covered area on consecutive sections (Fig. 1d). Interes-
tingly, by measuring the area occupied by swollen purple
fibers on H&E sections, we detected a trend towards
smaller necrotic areas in mTG mice compared to WT
controls (Fig. 1f). Complementary to those, the areas of
macrophage-positive staining on immunohistological
sections that correspond to actively regenerating areas on
H&E sections were significantly larger in injured mTGs
(Fig. 1e). This suggests that activation of macrophages is
enhanced in mTG animals and may contribute to a faster
regeneration. Alternatively, a potentially protective envi-
ronment in the uninjured mTG muscle could reduce
tissue necrosis and therefore require less M1 activation. In
either case, the earlier drop in M1 macrophage number in
the mTG could thus be a consequence of an accelerated
clean-up of necrotic tissue.
Multiple CTX injury results in reduced fibrosis in mTG
mice
The modulation of macrophage polarization observed in
mTGs could have other negative consequences. For
example, prolonged activation of macrophages can lead
to expansion of fibroblasts and excessive secretion of
extracellular matrix (ECM) components [21]. Although
these factors contribute to the regenerative process, their
removal at later stages of regeneration is essential in
order to fully restore functional skeletal muscle tissue
and to avoid excessive fibrotic tissue formation. There-
fore, to study fibrosis, repeated CTX injuries as a model
of chronic damage were used in order to exacerbate the
degeneration/regeneration process and increase fibrotic
tissue formation. Three weeks after the last of the three
CTX injections, we measured the hydroxyproline con-
tent in the whole muscle lysate as an indicator of fibro-
sis. Intriguingly, decreased fibrosis in the mTGs was
detected (Fig. 2a), in line with a higher drop in expres-
sion of several collagens and α-smooth muscle actin
(α-SMA) in the transgenic model between PBS- and
CTX-injected muscles (Fig. 2b, c).
Increased fibrosis and reduced necrotic debris clearance
in mKO mice
The modulation of macrophage polarization and the
inhibition of fibrosis in the repeated injury model imply
a beneficial effect of muscle PGC-1α on regeneration in
the mTG model. We therefore wanted to assess whether
muscle PGC-1α was required for proper clearance of ne-
crosis and fibrosis in mice with a muscle-specific ab-
lation of PGC-1α (mKOs).
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Fig. 1 (See legend on next page.)
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In order to study the role of PGC-1α in early events
of skeletal muscle regeneration, we generated muscle-
specific knockout mice (mKO) using myogenic factor
5 (Myf5)-cre to delete PGC-1α already at the muscle
progenitor stage. Analysis of these Myf5-mKO mice
confirmed the specific reduction in PGC-1α transcript
levels in different muscle beds as well as brown adipose
tissue (BAT) (Additional file 2A). Similar to other reported
PGC-1α mKO lines [9], endurance exercise capacity and
maximal oxygen consumption were reduced in Myf5-
mKOs (Additional file 2B–D). In contrast, the respiratory
exchange ratio (RER) at rest or during exercise trials was
unchanged between the genotypes (Additional file 2E).
Accordingly, the expression of several genes encod-
ing mitochondrial regulatory proteins was reduced
(Additional file 3B).
Indeed, increased fibrotic area (Masson’s trichrome
staining) and higher expression of collagens and α-SMA
were detected in the mKOs compared to WT littermates
after multiple CTX injections (Fig. 3a, b). Moreover, at
4 days after CTX, reduced clearance of necrotic debris
together with a tendency to smaller regenerating CD68+
macrophage area was observed in the loss-of-function
model for muscle PGC-1α (Fig. 3c–e). Interestingly, the
elevation of the expression of the M1 markers TNFα
and IL6 at 4 days post-CTX (Additional file 4) indicated
sustained activation of inflammation compared to the
mTG data (Fig. 1c). The results therefore imply a slower
inflammatory response to injury in muscle PGC-1α
loss-of-function.
Functional recovery of CTX-injected TA in mTG and mKO
mice at 10 days after injury
Based on the modulation of necrosis and fibrosis by
muscle PGC-1α, we subsequently studied functional
late-stage regeneration after CTX-induced muscle injury
using in situ contractility measurements on control
(PBS-injected) and injured (CTX-injected) TA muscles.
At the time point measured (10 days after CTX injection),
muscle functionality was partially restored. Surprisingly,
no difference in fatigue resistance or absolute maximal
force was found in any of the genotypes (Fig. 4). Thus,
specific gain- and loss-of-function of muscle PGC-1α
Fig. 2 Fibrosis after multiple cardiotoxin injections in mTG mice.
a Hydroxyproline measurement in mTG mice 3 weeks after the third
CTX injection; n = 3–4 per group; muscles from laminin α2-deficient
(dyw) and uninjected WT mice served as positive and negative
controls, respectively; b, c Relative mRNA levels of pro-fibrotic
genes at same the time point in PBS-injected muscles (b) and
CTX-injected muscles (c); CTX-injured muscle gene expression
levels were normalized to PBS levels of WT animals; n = 7–10
per group (t test); values are plotted as individual values or
average ± SEM; *p ≤ 0.05, **p ≤ 0.01; Abbreviations: Col collagen
(See figure on previous page.)
Fig. 1 Macrophages and tissue necrosis prior to and in early days after cardiotoxin injury in mTG mice. a FACS analysis of uninjured muscles of
WT and mTG animals, showing the proportion of pan-macrophages (F4/80+ cells), M1 macrophages (F4/80+CD80+CD163- cells), and M2 macro-
phages (F4/80+CD80−CD163+ cells); n = 5 per group; b proportion of pan-macrophages and M1 and M2 subpopulations in TA muscles of WT and
mTG animals 1 and 3 days after CTX injection using FACS analysis; n = 5–7 per group; c relative gene expression levels of M1 and M2 macrophage
markers in baseline condition (n = 5–6 per group) as well as 1 day (n = 3–4 per group) and 3 days (n = 5–7 per group) post-CTX-injection;
d representative immunohistochemistry (IHC) images (CD68: green; dapi/nuclei: blue; laminin: gray) and corresponding H&E sections showing
accumulation of macrophages (green in IHC images) in actively regenerating areas (dark purple in H&E staining); e measurement of area occupied by
M1 macrophages from IHC images; n = 7–8 per group; f measurement of necrotic area from H&E sections normalized to total section area;
n = 7–8 per group (t test); values are plotted as individual values or average ± SEM; *p≤ 0.05, **p≤ 0.01, ***p≤ 0.001
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affect early events in repair and regeneration without
altering the later stage of functional recovery.
Discussion
Proper muscle regeneration is not only important in the
context of pathological muscle injuries but also essential
for the incremental adaptation of muscle to exercise
[22]. Training not only offers protection against further
insults by altering muscle-intrinsic functions including
elevated oxidative capacity [23–25] but also results in
an acceleration of the regeneration process through in-
creased vascularity [26], adaptations of the neuromuscular
junction [27], and other muscle extrinsic changes [28].
Muscle PGC-1α is a key regulator of endurance training
adaptation and confers beneficial effects on muscle fiber
integrity and muscle functionality in a variety of different
muscle diseases. Using skeletal muscle-specific gain- and
loss-of-function animal models for PGC-1α, we now de-
scribe how PGC-1α affects macrophage-mediated clear-
ance of necrotic tissue and formation of fibrotic tissue in
the context of CTX-induced muscle damage.
Similar to the exercise-induced preconditioning of
muscles to improve regeneration, muscle-specific over-
expression of PGC-1α seems to be sufficient to prime
the muscle for faster regeneration, implied by the higher
number of pan- and a higher proportion of M2 macro-
phages. Modulation of necrosis clearance by altered
levels of PGC-1α correlated with a modulation of tissue
Fig. 3 Fibrosis, necrosis, and M1 macrophages after cardiotoxin injury in mKO mice. a Representative Masson’s trichrome stained section
with enlarged area and quantification of fibrotic area in mKO mice 3 weeks after the third CTX injection; n = 4–7 per group; b relative
mRNA levels of pro-fibrotic genes at the same time point; CTX-injured muscle gene expression levels were normalized to PBS levels of
WT animals; n = 6–7 per group (t test); c representative IHC images (CD68: green; dapi/nuclei: blue; laminin: gray) and corresponding H&E
sections showing accumulation of macrophages (green in IHC images) in actively regenerating area (dark purple in H&E staining); d measurement
of area occupied by M1 macrophages from IHC images; n = 5 per group; e measurement of necrotic area from H&E sections normalized to total
section area; n = 5 per group; values are plotted as average ± SEM; *p≤ 0.05, ***p≤ 0.001
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macrophage number and/or activity as well as the area
occupied by CD68+ macrophages. Intriguingly, since the
overall macrophage infiltration following CTX injection
remains unchanged between the WTs and mTGs, the
drop of M1-type macrophages after 3 days implies a
faster clean-up of necrosis and ensuing deactivation of
M1 macrophages in animals with elevated muscle PGC-
1α. Hence, although our experimental design was too
short to visualize the expected switch from M1 to M2
macrophages, the mTG mice have a potentially acceler-
ated early regeneration based on the lower proportion of
M1 macrophages. In fact, the PGC-1α-dependent acce-
leration of initiation of clearance of necrosis correlates
with a protection against fibrosis in animals with a repeti-
tive CTX-induced muscle injury. Inversely, the possible
delay not only in initiation but also in termination of
different regenerative events, as for example manifested
by the delayed clearance of necrotic areas, could contri-
bute to the increased fibrosis after multiple CTX injuries
in mKO animals.
Importantly, our two mouse models are not mirrored
in terms of the timing of overexpression and knockout
of PGC-1α. The expression of the transgene under the
MCK promoter in mTGs is expected in the adult myo-
fiber. In mKO mice, gene ablation is initiated already at
the muscle precursor stage driven by cre expression
controlled by the Myf5 promoter. As a consequence,
the observed changes in the early stages of regeneration
are almost certainly indirectly affected by the transgene,
whereas in the mKO model, both direct and indirect
effects are conceivable. Thus, to exclude possible con-
founding factors related to the contribution of satellite
Fig. 4 In situ TA contractility measurements 10 days after cardiotoxin injury in mTG and mKO mice. Absolute maximal force (P0) in
a mTG and e mKO mice; fatigue resistance in b mTG and f mKO mice; TA weight in c mTG and g mKO mice; specific maximal force
(P0/weight) in d mTG and h mKO mice; n = 8 per group for mTGs and n = 7–11 per group for mKOs; values are plotted as average ± SEM; *p≤ 0.05
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cells to regeneration in mKOs, we measured the kinetics
of myogenic regulatory factor (MRF) gene expression
before as well as at several time points after CTX injury
(Additional file 5A–E). Although the kinetics seems
slightly slower in the mKO model, no difference was
observed in the recovery of the functionality (Fig. 4e–h) of
the tissue.
Muscle PGC-1α expression has previously been associ-
ated with tissue inflammation. For example, a persistent
low-grade fiber damage in mKO animals is linked to
elevated pro-inflammatory gene expression in muscle as
well as systemic elevation of IL-6 and TNFα that might
lead to detrimental effects in other organs, e.g., pancre-
atic β-cells [29]. In line, reduced muscle PGC-1α expres-
sion in glucose intolerant and type 2 diabetic patients
significantly correlates with elevated IL-6 and TNFα
[29]. Inversely, elevation of PGC-1α in muscle cells
results in decreased activity of the nuclear factor κB
(NF-κB), the main regulator of pro-inflammatory gene
expression [30]. Importantly however, in other contexts,
the intrinsic effects of PGC-1α on muscle inflammation is
most likely masked by the much higher levels of these
genes in resident and infiltrating immune cells. For
example, in mice exposed to strong pro-inflammatory
stimuli, PGC-1α modulation in skeletal muscle affects
the expression of pro- and anti-inflammatory genes
[31, 32]. Similarly, the massive muscle damage elicited
by CTX injection leads to an elevation of immune
cell activation as reported here. Thus, the interplay
between muscle PGC-1α, inflammation, and immune cells
is multi-faceted and highly context-dependent [33, 34].
The changes in inflammatory and fibrotic processes
described in mTG mice are probably an indirect effect of
muscle PGC-1α-dependent remodeling of non-injured
tissue since muscle PGC-1α levels drop rapidly after CTX-
induced damage in WT and in mTG mice (Additional
file 6A) and slowly return to pre-injury levels in both
genotypes (Additional file 6B–E). Concomitantly, a sharp
reduction in PGC-1α-regulated mitochondrial genes
and recovery of their expression and functionality was
detected after injury, following the expression pattern
of PGC-1α in this context (Additional file 3). Based
on these observations, we hypothesize that PGC-1α over-
expression preconditions the intact muscle for a swift
response to injury. For example, the elevated levels of
M2 macrophages, the substantial reduction of the
pro-inflammatory IL-12, and the elevation of the anti-
inflammatory TGFβ could point towards a more pro-
tective environment in the muscles of mTG mice. It is
conceivable that subsequent to damage, the higher abun-
dance of macrophages and altered expression of various
chemo- and cytokines help to initiate a chain of events
that collectively accelerate multiple steps in early muscle
regeneration, e.g., upon CTX injury in mTGs. The secreted
phosphoprotein 1 (Spp1) is an example for a PGC-1α-
regulated factor produced and secreted from muscle cells
that activates macrophages even in non-injured skeletal
muscle tissue [35]. Furthermore, many of the observed
effects could at least in part be attributed to differential
expression of myostatin (Mstn) in both of our mouse
models prior to injury (Additional file 6F, G). Mstn is a
member of TGFβ family and a known inducer of fibrosis
[36]. Accordingly, Mstn−/− mice are protected against fibro-
sis formation upon notexin injury [37]. At the same time,
Mstn−/− mice exhibit faster recruitment of macrophages,
comparable to mTG mice. Therefore, Mstn−/− and PGC-1α
overexpression mouse model share similar regenerative
phenotypes, and consequently, the reduction of Mstn levels
in mTGs that exists already prior to injury could contribute
to the differences observed in the muscle-specific PGC-1α
gain-of-function mouse model. Mstn expression drops after
injury in WTanimals and slowly returns to pre-injury levels
[38] (Additional file 6F, G). In addition, lower and higher
levels of Mstn were detected late in the regeneration
process in mTG and mKO animals, respectively (Additional
file 6F, G). The contribution of Mstn to the modulation of
muscle regeneration downstream of PGC-1α will have to
be tested: such a specific involvement however could
provide an explanation for the regulation of Mstn by
PGC-1α in the absence of alteration of muscle mass [6].
Conclusions
In summary, we now provide evidence that muscles with
higher levels of PGC-1α are preconditioned for faster
resolution of inflammation and necrosis as well as a pre-
vention of fibrosis after repeated injury. Besides its central
role in exercise adaptation, the effect of PGC-1α on rege-
neration might contribute to the therapeutic potential of
elevation of PGC-1α in different muscle diseases and thus
reveal novel potential approaches for the treatment of
such pathologies.
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Additional file 1: List of qPCR primers. (DOC 47 kb)
Additional file 2: Characterization of Myf5-mKO mice. A) Relative
PGC-1α mRNA expression levels in various organs; mRNA levels in
mKO mice were normalized to WT (control littermate) levels; n = 6
per group; exercise capacity in mKO mice is reduced: B) time until
exhaustion, C) maximal speed reached, D) VO2 max, and E) respiratory
exchange ratio (RER) values before run and at exhaustion; n = 8–9 per
group; values are plotted as average ± SEM; *p≤ 0.05, **p≤ 0.01, ***p≤ 0.001;
Abbreviations: Gastro (gastrocnemius), Sol (soleus), QU (quadriceps),
TA (tibialis anterior), Edl (extensor digitorum longus), Diaph (diaphragm),
BAT (brown adipose tissue), WAT sc (white adipose tissue subcutaneous),
WAT vis (WAT visceral). (PDF 552 kb)
Additional file 3: PGC-1α functionality before and after cardiotoxin
injection. A-B) Relative mRNA expression levels of mitochondrial regulatory
genes in PBS-injected muscles of mTGs (n = 7–8 per group) (A) and
mKO mice (n = 5 per group) (B) 4 days after injection; (C–D) Relative mRNA
expression levels in CTX-injected muscles of mTGs (n = 7–8 per group) (C)
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and mKO mice (n = 5 per group) (D) 4 days after injection; E-F) NADH
staining of TA 19 days after PBS or CTX injections and signal intensity
measurement in mTG (n = 8–10 per group) (E) and mKO (n = 5 per
group) mice (F); (t-test). Lower values indicate darker staining (signal
intensity 0–255, where 0 corresponds to fully saturated signal and 255 to no
signal); values are plotted as average ± SEM; *p≤ 0.05, **p≤ 0.01, ***p≤ 0.001;
Abbreviations: PRC (PGC-1-related coactivator), Tfam (mitochondrial
transcription factor A), Gabpa (GA-binding protein alpha). (PDF 1565 kb)
Additional file 4: M1 and M2 marker expression in mKO mice before
and in early days after cardiotoxin injury. Relative gene expression A)
in the basal state in mKO mice (n = 4–6 per group), B) 2 days (n = 4
per group), and C) 4 days (n = 5 per group) after
CTX in mKO mice; CTX-injured muscle gene expression levels
were normalized to PBS levels of WT animals; values are plotted
as average ± SEM; *p ≤ 0.05, **p ≤ 0.01. (PDF 525 kb)
Additional file 5: Regeneration in mKO mice. A) Pax7, B) MyoD, C)
Myog, and D) MRF-4 gene expression 2 days (n = 4 per group), 4 days
(n = 5 per group), 7 days (n = 5 per group), 10 days (n = 8–12 per group),
and 19 days (n = 5 per group) after CTX injury; CTX-injured muscle
gene expression levels were normalized to PBS levels of corresponding
genotype; E) relative gene expression of the same genes in the basal,
uninjured state (n = 6 per group); mKO expression was normalized to WT
levels (t test); values are plotted as average ± SEM; *p≤ 0.05, **p ≤ 0.01.
(PDF 535 kb)
Additional file 6: PGC-1α and Mstn gene expression during course of
cardiotoxin-induced regeneration. Relative mRNA levels of PGC-1α in
mTG mice A) 8 h (n = 4–6 per group), B) 4 days (7–8 per group), C) 7 days
(n = 5 per group), D) 10 days (n = 8 per group), and E) 19 days (n = 8–10
per group) post-CTX; relative mRNA levels of Mstn 19 days after single
CTX injection in F) mTG (n = 8–10 per group) and G) mKO (n = 5 per
group) mice; values are plotted as average ± SEM; *p ≤ 0.05, ***p ≤ 0.001.
(PDF 185 kb)
Abbreviations
CTX: Cardiotoxin; mKO: Muscle-specific PGC-1α knockout mice; mTG: Muscle-
specific PGC-1α transgenic mice; PGC-1α: Peroxisome proliferator-activated
receptor γ coactivator 1α; TA: Tibialis anterior
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